| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Rani Therapeutics Holdings Inc. Class A Common Stock (NASDAQ: RANI)
RANI Technical Analysis
5
| As on 9th Jun 2023 RANI STOCK Price closed @ 5.04 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 12.33 & Strong Sell for SHORT-TERM with Stoploss of 17.80 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RANISTOCK Price
| Open | 5.03 | Change | Price | % |
| High | 5.18 | 1 Day | 0.09 | 1.82 |
| Low | 4.82 | 1 Week | 0.85 | 20.29 |
| Close | 5.04 | 1 Month | 0.45 | 9.80 |
| Volume | 65800 | 1 Year | -11.28 | -69.12 |
| 52 Week High 23.14 | 52 Week Low 3.92 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RANI Daily Charts |
RANI Intraday Charts |
Whats New @ Bazaartrend |
RANI Free Analysis |
|
|
RANI Important Levels Intraday
| RESISTANCE | 5.73 |
| RESISTANCE | 5.51 |
| RESISTANCE | 5.37 |
| RESISTANCE | 5.24 |
| SUPPORT | 4.84 |
| SUPPORT | 4.71 |
| SUPPORT | 4.57 |
| SUPPORT | 4.35 |
RANI Forecast May 2024
| 4th UP Forecast | 27.47 |
| 3rd UP Forecast | 20.28 |
| 2nd UP Forecast | 15.83 |
| 1st UP Forecast | 11.38 |
| 1st DOWN Forecast | -1.3 |
| 2nd DOWN Forecast | -5.75 |
| 3rd DOWN Forecast | -10.2 |
| 4th DOWN Forecast | -17.39 |
RANI Weekly Forecast
| 4th UP Forecast | 17.55 |
| 3rd UP Forecast | 13.54 |
| 2nd UP Forecast | 11.06 |
| 1st UP Forecast | 8.58 |
| 1st DOWN Forecast | 1.50 |
| 2nd DOWN Forecast | -0.98 |
| 3rd DOWN Forecast | -3.46 |
| 4th DOWN Forecast | -7.47 |
RANI Forecast2024
| 4th UP Forecast | 50.29 |
| 3rd UP Forecast | 35.78 |
| 2nd UP Forecast | 26.81 |
| 1st UP Forecast | 17.84 |
| 1st DOWN Forecast | -7.76 |
| 2nd DOWN Forecast | -16.73 |
| 3rd DOWN Forecast | -25.7 |
| 4th DOWN Forecast | -40.21 |
Rani Therapeutics Holdings Inc. Class A Common Stock ( NASDAQ USA Symbol : RANI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RANI Business Profile
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-103, a glucagon-like peptide-1 mimetic to treat type 2 diabetes; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California. Address: 2051 Ringwood Avenue, San Jose, CA, United States, 95131
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service